Two cases of hydroa vacciniforme-like lymphoproliferative disease controlled by anti-inflammatory agents.
- Young Jae Kim,
- Sun Young Choi,
- Woo Jin Lee,
- Chong Hyun Won,
- Sung Eun Chang,
- Jee Ho Choi,
- Mi Woo Lee
Photodermatol Photoimmunol Photomed 2017 May 24. Epub 2017 May 24.
Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Hydroa vacciniforme-like lymphoproliferative disease (HVLL) was first described as the coexistence of hydroa vacciniforme and malignant lymphoma in 1986. It was renamed in the 2008 World Health Organization classification system as one of the Epstein-Barr virus (EBV)-associated lymphoproliferative diseases (LPDs) of childhood. HVLL has T cell monoclonality and is considered a rare EBV(+) cutaneous T cell lymphoproliferative disease. Read More